Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nicholas Johnson, MD, MSCI, FAAN
Virginia Commonwealth University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Das Clínicas, University of São Paulo School of Medicine (hcfmusp)
Cerqueira César, São Paulo, Brazil
Clara Gontijo Camelo, MD, PhDNot, yet, recruiting
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Aravindhan Veerapandiyan, MDNot, yet, recruiting - University of Kansas Medical Center
Kansas City, Kansas, United States
Jeffrey Statland, MDNot, yet, recruiting - Virginia Commonwealth University
Richmond, Virginia, United States
Nicholas E Johnson, MD, MSCI, FAANRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jun 2025
- Primary completion
- 30 Jun 2030
- Completion
- 30 Jun 2030
- Last update posted
- 11 Aug 2026
- Registered enrollment
- 200
- Registry id
- NCT06747884
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.